Sociedad Americana de Hirudoterapia

In-depth profiles of bioactive large molecules in saliva secretions of leeches determined by combining salivary gland proteome and transcriptome data

Omics article published in Journal of Proteomics (2019)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Preclinical (animal)Genómica y proteómicaFarmacología salivalLiu Z, Tong X, Su Y et al. · Journal of proteomics, 2019

Abstract

Medicinal leeches have been widely utilized in medical procedures for thousands of years. The application of leeches depends on the components of leech saliva secretions and active molecules, but many components of the secretions are not well characterized due to their low concentration and abundance. Determination of the profiles of leech salivary secretions is important to its medicinal application. In this study, we performed an in-depth proteomic analysis of leech salivary glands and deduced 434 full-length protein sequences from combined leech proteome and transcriptome databases. After integrating data from both datasets, forty-four proteins and two hundred twenty-one transcripts of bioactive molecules were involved in leech sucking pathways. Using gene expression analysis, we found that two-thirds of bioactive genes played key roles in leech bite processes and were associated cave-dwelling habitats. Our results indicate that the treatment efficiency can differ depending on the sucking leech species. Moreover, combining high-throughput proteomic and transcriptomic analyses is effective for the determination of wide profiles of proteins that are present at low concentrations in secretions. These findings highlight the extensive diversity of bioactive molecules and provide a new foundation for performing novel investigations and discovering future pharmacological agents or targets in leech medicinal therapy. SIGNIFICANCE: Medicinal leech therapy has been used for many centuries depending on the components of leech saliva secretions and active actions, but many components of the secretions were less known due to its low concentration and abundance. Determination of the profiles of leech salivary secretions is important to its medicinal application. Hereby, the molecular information provided by proteomic and transcriptomic analysis can be used to develop a more thorough understanding of leech sucking pathway and medicinal application. It provided a new foundation for performing novel investigations and discovering future pharmacological agents or targets in leech medicinal therapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsLeechesProteomeSalivaSalivary GlandsSalivary Proteins and PeptidesTranscriptome

Resumen

Combined proteomic and transcriptomic analysis deduces 434 full-length salivary protein sequences and identifies 44 proteins and 221 transcripts of bioactive molecules across multiple medicinal leech species, mapping the molecular diversity of leech saliva.

Por qué esto importa para la hirudoterapia

Este estudio realizó un análisis proteómico y transcriptómico en profundidad de las glándulas salivales de la sanguijuela, deduciendo 434 secuencias proteicas de longitud completa e identificando 44 proteínas bioactivas y 221 transcripts involucrados en las vías de succión de la sanguijuela. Los investigadores hallaron que aproximadamente dos tercios de los genes bioactivos desempeñaron funciones clave en el proceso de mordedura de la sanguijuela y se asociaron con hábitats cavernícolas, y señalaron que la eficiencia del tratamiento puede diferir según la especie de sanguijuela chupadora. Para el ámbito de ASH, este estudio caracteriza directamente la diversidad molecular de la saliva de la sanguijuela —el fundamento farmacológico de la terapia medicinal con sanguijuelas— y proporciona un recurso para el descubrimiento de futuros agentes farmacológicos. Limitación: se trata de un estudio descriptivo de perfil molecular que emplea ómicas de alto rendimiento; no aporta datos de eficacia clínica ni medidas de resultados terapéuticos.

Citación

In-depth profiles of bioactive large molecules in saliva secretions of leeches determined by combining salivary gland proteome and transcriptome data.

Liu Z, Tong X, Su Y et al. · Journal of proteomics, 2019

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.